CN1628749A - Eatable ants and its preparation method - Google Patents
Eatable ants and its preparation method Download PDFInfo
- Publication number
- CN1628749A CN1628749A CNA2004100096890A CN200410009689A CN1628749A CN 1628749 A CN1628749 A CN 1628749A CN A2004100096890 A CNA2004100096890 A CN A2004100096890A CN 200410009689 A CN200410009689 A CN 200410009689A CN 1628749 A CN1628749 A CN 1628749A
- Authority
- CN
- China
- Prior art keywords
- formica fusca
- lixiviating solution
- filter
- enzymolysis
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 241000257303 Hymenoptera Species 0.000 title 1
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 239000002775 capsule Substances 0.000 claims abstract description 18
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 16
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 16
- 235000008397 ginger Nutrition 0.000 claims abstract description 16
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 13
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 11
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 11
- 229960004853 betadex Drugs 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 9
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 6
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 6
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 6
- 102000016943 Muramidase Human genes 0.000 claims abstract description 5
- 108010014251 Muramidase Proteins 0.000 claims abstract description 5
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 5
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 5
- 229960000274 lysozyme Drugs 0.000 claims abstract description 5
- 239000004325 lysozyme Substances 0.000 claims abstract description 5
- 241001251068 Formica fusca Species 0.000 claims description 76
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- 238000000855 fermentation Methods 0.000 claims description 25
- 230000004151 fermentation Effects 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 19
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 18
- 229940088598 enzyme Drugs 0.000 claims description 18
- 241000234314 Zingiber Species 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 15
- 238000005516 engineering process Methods 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 12
- 235000013376 functional food Nutrition 0.000 claims description 11
- 239000011812 mixed powder Substances 0.000 claims description 10
- 229940046011 buccal tablet Drugs 0.000 claims description 7
- 239000006189 buccal tablet Substances 0.000 claims description 7
- 238000010411 cooking Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 101710130006 Beta-glucanase Proteins 0.000 claims description 5
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 claims description 5
- 239000005909 Kieselgur Substances 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 229940068682 chewable tablet Drugs 0.000 claims description 5
- 239000007910 chewable tablet Substances 0.000 claims description 5
- 239000000084 colloidal system Substances 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 101710180319 Protease 1 Proteins 0.000 claims description 3
- 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 2
- 239000002131 composite material Substances 0.000 abstract description 3
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 19
- 230000000694 effects Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 8
- 239000011573 trace mineral Substances 0.000 description 8
- 235000013619 trace mineral Nutrition 0.000 description 8
- 239000011701 zinc Substances 0.000 description 8
- 229910052725 zinc Inorganic materials 0.000 description 8
- 235000016804 zinc Nutrition 0.000 description 8
- 239000011669 selenium Substances 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000011572 manganese Substances 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- 235000011649 selenium Nutrition 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- -1 steroid compounds Chemical class 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010067472 Organising pneumonia Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241001620634 Roger Species 0.000 description 2
- 241000032211 Terebra Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000023367 bronchiolitis obliterans with obstructive pulmonary disease Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- 201000009805 cryptogenic organizing pneumonia Diseases 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241001507629 Formicidae Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001646976 Linepithema humile Species 0.000 description 1
- 101710132682 Lysozyme 1 Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001078625 Plagiolepis alluaudi Species 0.000 description 1
- 101710180316 Protease 2 Proteins 0.000 description 1
- 101710180313 Protease 3 Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 1
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229940094933 n-dodecane Drugs 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Disclosed is an eatable ant food and its preparation method, wherein the food is prepared from traditional medicinal composite matrimony vine lixiviating liquid 3-15%, Chinese date lixiviating liquid 5-18%, fresh ginger lixiviating liquid 3-16%, composite proteinase 1-3%, lysozyme 0.5-1%, beta-dextranase 0.05-0.1%, and the amount of added beta-cyclodextrin in the oral liquid is 0.2-1.0%, the amount of added beta-cyclodextrin in the capsule is 1-5%, the amount of added beta-cyclodextrin in the lozenge is 1-8%, the amount of maltodextrin is 5-15%.
Description
Technical field:
The present invention relates to a kind of is primary raw material with the edible Formica fusca, utilize to concentrate enzymolysis solution and possess that dietotherapeutic Chinese medicine complex liquid fermenting process of preparing goes out Ants Wine, compound Formica fusca oral liquid and based on enzymolysis solution, be aided with beta-schardinger dextrin-, the sheet agent aid is prepared into the Formica fusca functional food with multi-efficiency and good mouthfeel, packaged form can be concentrated oral liquid, capsule or buccal tablet.
Background technology:
Formica fusca is one of nature three great society insecticides.The whole world has 260 to belong to, and kind surplus in the of 16000 is the hugest and the most prosperous family of biological world.Our ancestors have found the medical care effect of Formica fusca very early, and the mankind are exploring always, developing this treasure-house.Nowadays, unrivaled characteristics of Formica fusca and medical value have caused the extensive concern of medical circle.
Formica fusca is the maximum insecticide of nature quantity, is exactly the dietetic therapy good merchantable brand since ancient times.Studies show that in recent years: Formica fusca is nutritious, and gross protein value is more than 50%, and is rich in the essential amino acids of needed by human body, and the content of its inorganic salt and vitamin is also higher, and particularly the content of zinc is up to more than the 200mg/kg.VE and contains the various active composition also about 20mg/kg.Pharmacological research shows: Formica fusca has antiinflammatory, analgesia, adjusting immunity of organisms and the anti-ageing effect of waiting for a long time.Generally acknowledged that at present both at home and abroad Formica fusca is one of health functional food resource of being worth of tool exploitation.
Formica fusca has another name called " XUANJU " in Compendium of Material Medica, have effects such as " QI invigorating, damp face, lactogenic, activating blood circulation to dissipate blood stasis, wind dispelling cold expelling, the kidney invigorating nourishing the liver, spleen invigorating ".Modern medicine thinks that Formica fusca has one's own knack to treatment rheumatic arthritis.Ratified through Ministry of Public Health in 1992, Formica fusca can be used as the health food of medicine-food two-purpose, its body inner protein 46～67%, it is 1 times of Semen Glycines, 2 times of beef, its in contained 28 in the free amino acid 8 kinds be needed by human but human body can not be synthetic, also have 20 various trace elements such as vitamin B1, B2, B12, E and zinc, manganese, selenium, ferrum, calcium, phosphorus.The content of zinc is the abundantest in the trace element, and per 1000 gram Formica fuscas contain 120～198 milligrams on zinc, are 8 times of Semen sojae atricolor zinc content, 3 times of Hepar Sus domestica zinc content, and this is unique in field of food.Also contain plurality of enzymes, steroid compounds, triterpenoid, citral, formic acid etc.Therefore, the nutritionist claims that Formica fusca is " miniature nutrition treasure-house " and " natural drug processing factory ".
The U.S., Germany carry out macromethod research to the multiple Formica fusca of Formicidae, prove that Formica fusca contains special aldehyde compound.As citral (C10H16O), also claim the cursive script formaldehyde, this is different with the formaldehyde (HCHO) (claiming formaldehyde again) that people know already.Analyze breast formaldehyde (C10H14O), rainbow formaldehyde (C10H16O) from Argentine ant; Belong to the class Formica fusca from little yellow ant and analyze Herba Cymbopogonis Citrari terpene, Fructus Citri Limoniae terpene etc.; The phosphorus-containing compound adenosine triphosphate (ATP) that also has high energy, plurality of enzymes and coenzyme.The terebra gland of Formica fusca contains formic acid, alkaloid, histamine, positive certain herbaceous plants with big flowers alcohol, n-undecane alcohol, n-dodecane alcohol.Physician's animal experiment proves that the terebra gland of a Formica fusca injects rat, and effect is equivalent to the thyroliberin (ACTH) that 6 units tire.Once thought before 10 years that the main pharmacodynamics body-building composition of Formica fusca was the white blood Jujube cursive script formaldehyde of Formica fusca, finding by further investigation in recent years that drug effect of Formica fusca and body-building composition were multiple bioactive substance comprehensive functions, rather than the effect of single component.The BETTY BOOP professor of the Australia sharp university of Mike declares through after the multiple research why Formica fusca seldom catches an illness, and is because Formica fusca divides the antibiotics that contains in the secret waxy substance can control the event of infectious disease among the ant group effectively.The up-to-date experimental study of carrying out at her confirms that also above-mentioned antibiotics also helps human body to resist multiple pathogenic microorganism, and is obvious especially in the effect that tackles aspect fungal infection and the staphylococcus aureus.The BETTY BOOP professor just cooperates with a tame Britain drugmaker, her achievement in research is converted into the new drug of " Formica fusca antibiotics ", to promote the well-being of mankind.
For thousands of years, eat Formica fusca and with the custom of Formica fusca as health food, wide-spread between China various nationalities.
In recent years, be that report and the technology that main raw material(s) is produced health food and functional food day by day increases with the Formica fusca, excellent in alcohol product.At present, the processing technique of health ant wine mainly is to adopt water or Ethanol Method to extract active ingredient in the Formica fusca, join in the cereal fermentation liquor, through blending form or in the process of blending, be aided with corresponding Chinese crude drug, to improve its effect.The then employing ethanol extraction that has is made into concentrated type extractum behind the recovery ethanol, and refabrication becomes corresponding Formica fusca product.
What have then is Formica fusca to be baked to dried, makes Related product or is aided with Chinese medicine and make related drugs.
Adopt CO in addition
2The potent complex extractions thing that supercritical technology extracts, this method fixed investment is big, the running cost height, technology control difficulty is big.
Wall breaking technology can improve the active ingredient leaching rate of product, is convenient to absorption of human body.Biological enzymolysis can be reduced to lower-molecular substance with macro-molecular protein, is more conducive to absorption of human body, increases product efficacy.This technology fixed investment is little, and technology is simple, active ingredient extraction efficiency height, and raciness.
Summary of the invention:
The purpose of this invention is to provide a kind of wall breaking technology that utilizes with the Formica fusca broken wall treatment, through biological enzymolysis, and be aided with the Chinese medicine lixiviating solution, prepare health ant wine through microbial fermentation, take off Ethanol Treatment and prepare oral liquid through concentrating, adjuvant in addition, preparation health care concentrated oral liquid, capsule or buccal tablet be Formica fusca functional food of primary raw material and preparation method thereof with edible Formica fusca.
Technical scheme of the present invention:
Production technology:
1) broken wall treatment: with the Formica fusca of selected remove impurity,, adjust its gap to 5～30 μ m with supermicro mill or colloid mill, overground repeatedly 3～5 times to the homogenate shape;
2) enzymolysis processing: the compound enzyme of getting compound protease 1～3%, lysozyme 0.5～1%, 1,4 beta-glucanase 0.05～0.1% composition by Formica fusca homogenate weight ratio, enzymolysis processing is carried out in Formica fusca homogenate, 45～55 ℃ of hydrolysis temperatures, enzymolysis time 6 hours, after enzymolysis finishes, adopt 10 minutes enzyme denaturing of boiling water heating, be cooled to below 40 ℃ standby;
3) fermentation: will eluriate clean Semen oryzae sativae and cook, Semen oryzae sativae after cooking is cooled to below 40 ℃, get Semen oryzae sativae 60～70%, the Formica fusca enzymolysis solution 30～40% behind the enzyme denaturing stirs, and is that radix is got wine yeast 2～5 ‰ and mixed thoroughly with said mixture and begin fermentation with need inoculations Semen oryzae sativae weight;
4) filter: fermenting mixture adopts squeezing and pressing method to filter, the screw rod squeezing that equipment choosing yellow wine industry is commonly used
Machine or plate and frame type filter-press, control filter screen 60 orders get the just fermentation liquid for preparing of filtrate;
5) soak allotment: Fructus Lycii, Fructus Jujubae, fresh ginger are crushed to 1～3cm respectively, get respectively and place food grade ethanol, concentration 30 degree, ratio is 1: 3～5, soaks, soak 72h, adopt filter cloth to leach residue, residue added fermentation in the lump in the fermenting mixture, with ferment filtrate weight be radix with the Fructus Lycii lixiviating solution by 3～15 ‰, the Fructus Jujubae lixiviating solution is by 5～18 ‰, and the fresh ginger lixiviating solution joins in the ferment filtrate in 3～16 ‰ ratio and allocates;
6) secondary filter: adopt diatomaceous earth filter to filter;
7) concentrate: use vacuum concentration pan to remove ethanol and be concentrated into soluble solid 〉=10%, ethanol content≤3%;
8) tabletting: deployed mixed powder directly is pressed into chewable tablet, deployed mixed powder is directly made capsule by capsule machine.
Formica fusca and trace element
Human body contains 60 various trace elements, and there have some to belong to human body institute to be essential, and content is more constant in tissue, in case shortage ought replenishing unusually of structure and function can occur then recover normal.Micro elements needed by human is at present known 14 kinds, be selenium (Se), zinc (Zn), manganese (Mn), ferrum (Fe), cobalt (Co), copper (Cu), iodine (I), molybdenum (Mo), chromium (Cr), nickel (Ni), stannum (Sn), silicon (Si), fluorine (F), vanadium (V), wherein 5 kinds just were determined before and after 1970.Manganese in 14 kinds of indispensable elements, zinc, selenium, ferrum, iodine, copper are important.
Formica fusca taste Jiamei, nutritious, wherein contain important trace element, play obvious diseases prevention, disease cure function and defying age effect.
The pharmacology of Peking University is that Formica fusca development group has been carried out series of studies to the pharmacological action of Polyhachis vicina Roger aqueous extract, records micronutrient levels such as following table in the Formica fusca body:
Micronutrient levels in the Formica fusca body
| Project | The Polyhachis vicina Roger trace elements determination | ||||
| Selenium (Se) | Manganese (Mn) | Zinc (Zn) | Copper (Cu) | Ferrum (Fe) | |
| Full ant powder (umol/kg) | ????10.14 | ????9186.4 | ????7440.8 | ????98.2 | ????10743.1 |
| Ant liquid (umol/L) | ????5.60 | ????3949.8 | ????1670.74 | ????22.0 | ????358.1 |
| Normal saline (umol/L) | ????0 | ????0 | ????63.3 | ????31.5 | ????69.1 |
In recent years, the beverage that contains trace element is both at home and abroad seen many day by day, is used for the gerocomia product of slow down aging and helps the Rare Elements Preparations of upgrowth and development of children also increasing.But the nutritionist thinks: contain the food of ant extract, its value is far superior to these artificial preparations.The one, containing zinc, manganese, selenium is most important parts in the needed by human body trace element; The 2nd, its existence form mostly is organic salt, and benefit is absorbed by human body; The 3rd, rise and to be present in the Formica fusca body, ratio is natural rationally, and without any side effects.
Medical value of Formica fusca and edibility have long history, and Formica fusca is as ticbit, also as nourishing and health care good medicine, integrate cuisines, medical treatment and nourish, and be subjected to domestic and international gourmet's favor already deeply.According to motherland's traditional medical theory, Formica fusca nature and flavor Gan Pinglve is temperature partially, and the effect of strengthening the body resistance, invigorating the kidney and strengthening the bones, the strong muscle of nourishing the liver, spleen invigorating granulation promoting, expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling is arranged.According to animal energy, content, effect principle, Formica fusca can be born the 400 times of weight of self, draw heavy 1700 times, so be called " power god ".Through modern medicine pharmacology test shows, the Formica fusca coelomic fluid is that at present artificial production can't synthetic cursive script formaldehyde more than 90%, and the dried ant of per 100 grams can produce 700 kilocalorie heats, and this material is playing an important role aspect mediator's body immunity function.
Technological merit of the present invention:
1. the present invention adopts wall breaking technology to handle, and makes that effective component is easier to comprehensive stripping in the Formica fusca.
2. complex enzyme degradation makes product functionality stronger.
3. the compound co-fermentation of enzymolysis solution and corn can further make the active ingredient in the Formica fusca all be dissolved in the wine solution by fermentation energy on the one hand, can well improve the bad flavor of Formica fusca product simultaneously by composite fermentation.
4. adopt the biological extraction method, kept intravital nutrient of Formica fusca and effective ingredient to greatest extent.Being the nutrition delicacies, also is the treasure of medicated diet, confirms through functional experiment, has enhancing immunity, removes free radical, improves sleep, the effect of blood-enriching face-nourishing and the bone and muscle strengthening of replenishing the calcium.To arteriosclerosis, suffer from a deficiency of the kidney, sexual impotence, liver function disease, neurasthenia, cerebral infarction sequela, malignant tumor etc. all have the improvement effect, particularly rheumatism, rheumatoid, hypertension, diabetes etc. are had special efficacy.
Description of drawings
The technological process of Fig. 1 Formica fusca functional food.
The specific embodiment:
Embodiment 1
The present invention is a kind of Formica fusca functional food of black multi-thorn ant, it is characterized in that it is the product made from the raw material and the process of following weight ratio:
Prescription:
The Fructus Lycii lixiviating solution is by 10 ‰
The Fructus Jujubae lixiviating solution is by 12 ‰
The fresh ginger lixiviating solution is by 5 ‰
β--cyclodextrin is 1.0 ‰ (adding in oral liquid)
Cycloheptaamylose is 6%, the maltodextrin consumption is 8% (adding in the buccal tablet)
β--cyclodextrin consumption is 3% (adding in the capsule)
All the other are edible Formica fusca
Production technology
1) broken wall treatment: with the Formica fusca of selected remove impurity,, adjust its gap to 5～30 μ m with supermicro mill or colloid mill, overground repeatedly 3～5 times to the homogenate shape;
2) enzymolysis processing: the compound enzyme that adopts compound protease 3%, lysozyme 1%, 1,4 beta-glucanase 0.1% (all being radix with homogenate) to form carries out enzymolysis processing to homogenate, 45～55 ℃ of hydrolysis temperatures, enzymolysis time 6 hours, after enzymolysis finishes, adopt 10 minutes enzyme denaturing of boiling water heating, be cooled to below 40 ℃ standby;
3) fermentation: will eluriate clean Semen oryzae sativae and cook.Semen oryzae sativae after cooking 70% cools to below 40 ℃, and the Formica fusca enzymolysis solution 30% behind the enzyme denaturing stirs, and gets wine yeast 2～5 ‰ (is radix with need inoculations Semen oryzae sativae weight) and mixes thoroughly with said mixture and begin fermentation;
4) filtration: fermenting mixture adopts squeezing and pressing method to filter, screw press or plate and frame type filter-press that equipment choosing yellow wine industry is commonly used, and control filter screen 60 orders get the just fermentation liquid for preparing of filtrate;
5) soak allotment: Fructus Lycii, Fructus Jujubae, fresh ginger are crushed to 1～3cm respectively, get respectively and place food grade ethanol (more than concentration 30 degree), ratio is 1 part: soak in 5 parts, soak 72h, adopt filter cloth to leach residue.Residue is added fermentation in the lump in the fermenting mixture.By 15 ‰, the Fructus Jujubae lixiviating solution is by 18 ‰ with whole Fructus Lycii lixiviating solution of obtaining, and the fresh ginger lixiviating solution joins in the ferment filtrate and allocates in 16 ‰ ratio (is radix with ferment filtrate weight);
6) secondary filter: adopt diatomaceous earth filter to filter;
7) concentrate.Use vacuum concentration pan to remove ethanol and be concentrated into soluble solid 〉=10%, ethanol content≤below 3%;
8) tabletting: deployed mixed powder directly is pressed into chewable tablet, deployed mixed powder is directly made capsule by capsule machine.
Embodiment 2
The present invention is a kind of Formica fusca functional food of black multi-thorn ant, it is characterized in that it is the product made from the raw material and the process of following weight ratio:
Prescription:
The Fructus Lycii lixiviating solution is by 7 ‰
The Fructus Jujubae lixiviating solution is by 12 ‰
The fresh ginger lixiviating solution is by 7 ‰
β--cyclodextrin is 0.2 ‰ (adding in oral liquid)
Cycloheptaamylose is 3%, the maltodextrin consumption is 12% (adding in the buccal tablet)
β--cyclodextrin consumption is 4% (adding in the capsule)
All the other are edible Formica fusca
Production technology
1) broken wall treatment: with the Formica fusca of selected remove impurity,, adjust its gap to 5～30 μ m with supermicro mill or colloid mill, overground repeatedly 3～5 times to the homogenate shape;
2) enzymolysis processing: adopt compound protease 1%, lysozyme 0.5%, 1,4 beta-glucanase 0.05%
The compound enzyme that (all being radix with homogenate) formed carries out enzymolysis processing to homogenate, 45～55 ℃ of hydrolysis temperatures, and enzymolysis time 6 hours after enzymolysis finishes, adopts 10 minutes enzyme denaturing of boiling water heating, is cooled to below 40 ℃ standby;
3) fermentation: will eluriate clean Semen oryzae sativae with cooking.Semen oryzae sativae after cooking 60% cools to below 40 ℃, and the Formica fusca enzymolysis solution 40% behind the enzyme denaturing stirs, and gets wine yeast 2 ‰ (is radix with need inoculations Semen oryzae sativae weight) and mixes thoroughly with said mixture and begin fermentation;
4) filtration: fermenting mixture adopts squeezing and pressing method to filter, screw press or plate and frame type filter-press that equipment choosing yellow wine industry is commonly used, and control filter screen 60 orders get the just fermentation liquid for preparing of filtrate;
5) soak allotment: Fructus Lycii, Fructus Jujubae, fresh ginger are crushed to 1～3cm respectively, get respectively and place food grade ethanol (more than concentration 30 degree), ratio is 1 part: soak in 3 parts, soak 72h, adopt filter cloth to leach residue.Residue is added fermentation in the lump in the fermenting mixture.By 3 ‰, the Fructus Jujubae lixiviating solution is by 5 ‰ with whole Fructus Lycii lixiviating solution of obtaining, and the fresh ginger lixiviating solution joins in the ferment filtrate and allocates in 3 ‰ ratio (is radix with ferment filtrate weight);
6) secondary filter: adopt diatomaceous earth filter to filter;
7) concentrate: use vacuum concentration pan to remove ethanol and be concentrated into soluble solid 〉=10%, ethanol content≤below 3%;
8) tabletting: deployed mixed powder directly is pressed into chewable tablet, deployed mixed powder is directly made capsule by capsule machine.
Embodiment 3
The present invention is a kind of Formica fusca functional food of black multi-thorn ant, it is characterized in that it is the product made from the raw material and the process of following weight ratio:
Prescription:
The Fructus Lycii lixiviating solution is by 15 ‰
The Fructus Jujubae lixiviating solution is by 18 ‰
The fresh ginger lixiviating solution is by 16 ‰
β--cyclodextrin is 0.8 ‰ (adding in oral liquid)
Cycloheptaamylose is 8%, the maltodextrin consumption is 5% (adding in the buccal tablet)
β--cyclodextrin consumption is 2% (adding in the capsule)
All the other are edible Formica fusca
Production technology
1) broken wall treatment: with the Formica fusca of selected remove impurity,, adjust its gap to 5～30 μ m with supermicro mill or colloid mill, overground repeatedly 5 times to the homogenate shape;
2) enzymolysis processing: adopt compound protease 2%, lysozyme 0.7%, 1,4 beta-glucanase 0.5%
The compound enzyme that (all being radix with homogenate) formed carries out enzymolysis processing to homogenate.45～55 ℃ of hydrolysis temperatures, enzymolysis time 6 hours.After enzymolysis finishes, adopt 10 minutes enzyme denaturing of boiling water heating, be cooled to below 40 ℃ standby;
3) fermentation: will eluriate clean Semen oryzae sativae with cooking.Semen oryzae sativae after cooking 65% cools to below 40 ℃, and the Formica fusca enzymolysis solution 35% behind the enzyme denaturing stirs, and gets wine yeast 3 ‰ (is radix with need inoculations Semen oryzae sativae weight) and mixes thoroughly with said mixture and begin fermentation;
4) filtration: fermenting mixture adopts squeezing and pressing method to filter, screw press or plate and frame type filter-press that equipment choosing yellow wine industry is commonly used, and control filter screen 60 orders get the just fermentation liquid for preparing of filtrate;
5) soak allotment: Fructus Lycii, Fructus Jujubae, fresh ginger are crushed to 1～3cm respectively, get respectively and place food grade ethanol (more than concentration 30 degree), ratio is 1 part: soak in 5 parts, soak 72h, adopt filter cloth to leach residue.Residue is added in the fermenting mixture fermentation in the lump, and by 3～15 ‰, the Fructus Jujubae lixiviating solution is by 9 ‰ with whole Fructus Lycii lixiviating solution of obtaining, and the fresh ginger lixiviating solution joins in the ferment filtrate and allocates in 8 ‰ ratio (is radix with ferment filtrate weight);
6) secondary filter: adopt diatomaceous earth filter to filter.
7) concentrate: use vacuum concentration pan to remove ethanol and be concentrated into soluble solid 〉=10%, ethanol content≤below 3%;
8) tabletting: deployed mixed powder directly is pressed into chewable tablet, deployed mixed powder is directly made capsule by capsule machine.
Claims (2)
1. the manufacture method of a Formica fusca functional food, it is characterized in that: it is the product made from the raw material of following weight ratio and process:
Prescription:
The Fructus Lycii lixiviating solution is by 3～15 ‰
The Fructus Jujubae lixiviating solution is by 5～18 ‰
The fresh ginger lixiviating solution is by 3～16 ‰
β--cyclodextrin is 0.2～1.0 ‰, adds in oral liquid
β--the cyclodextrin consumption is 1～5%, adds in the capsule
Cycloheptaamylose is 1～8%, the maltodextrin consumption is 5～15%, adds in the buccal tablet
All the other are edible Formica fusca
Production technology:
1) broken wall treatment: with the Formica fusca of selected remove impurity,, adjust its gap to 5～30 μ m with supermicro mill or colloid mill, overground repeatedly 3～5 times to the homogenate shape;
2) enzymolysis processing: the compound enzyme of getting compound protease 1～3%, lysozyme 0.5～1%, 1,4 beta-glucanase 0.05～0.1% composition by Formica fusca homogenate weight ratio, enzymolysis processing is carried out in Formica fusca homogenate, 45～55 ℃ of hydrolysis temperatures, enzymolysis time 6 hours, after enzymolysis finishes, adopt 10 minutes enzyme denaturing of boiling water heating, be cooled to below 40 ℃ standby;
3) fermentation: will eluriate clean Semen oryzae sativae and cook, Semen oryzae sativae after cooking is cooled to below 40 ℃, get Semen oryzae sativae 60～70%, the Formica fusca enzymolysis solution 30～40% behind the enzyme denaturing stirs, and is that radix is got wine yeast 2～5 ‰ and mixed thoroughly with said mixture and begin fermentation with need inoculations Semen oryzae sativae weight;
4) filter: fermenting mixture adopts squeezing and pressing method to filter, the screw rod squeezing that equipment choosing yellow wine industry is commonly used
Machine or plate and frame type filter-press, control filter screen 60 orders get the just fermentation liquid for preparing of filtrate;
5) soak allotment: Fructus Lycii, Fructus Jujubae, fresh ginger are crushed to 1～3cm respectively, get respectively and place food grade ethanol, concentration 30 degree, ratio is 1: 3～5, soaks, soak 72h, adopt filter cloth to leach residue, residue added fermentation in the lump in the fermenting mixture, with ferment filtrate weight be radix with the Fructus Lycii lixiviating solution by 3～15 ‰, the Fructus Jujubae lixiviating solution is by 5～18 ‰, and the fresh ginger lixiviating solution joins in the ferment filtrate in 3～16 ‰ ratio and allocates;
6) secondary filter: adopt diatomaceous earth filter to filter;
7) concentrate: use vacuum concentration pan to remove ethanol and be concentrated into soluble solid 〉=10%, ethanol content≤3%;
8) tabletting: deployed mixed powder directly is pressed into chewable tablet, deployed mixed powder is directly made capsule by capsule machine.
2. Formica fusca functional food is characterized in that: it is that method according to claim 1 is made
Prescription:
The Fructus Lycii lixiviating solution is by 3～15 ‰
The Fructus Jujubae lixiviating solution is by 5～18 ‰
The fresh ginger lixiviating solution is by 3～16 ‰
β--cyclodextrin is 0.2～1.0 ‰, adds in oral liquid
β--the cyclodextrin consumption is 1～5%, adds in the capsule
Cycloheptaamylose is 1～8%, the maltodextrin consumption is 5～15%, adds in the buccal tablet
All the other are edible Formica fusca.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100096890A CN1275545C (en) | 2004-10-20 | 2004-10-20 | Eatable ants and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100096890A CN1275545C (en) | 2004-10-20 | 2004-10-20 | Eatable ants and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1628749A true CN1628749A (en) | 2005-06-22 |
| CN1275545C CN1275545C (en) | 2006-09-20 |
Family
ID=34845517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100096890A Expired - Fee Related CN1275545C (en) | 2004-10-20 | 2004-10-20 | Eatable ants and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1275545C (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101669646B (en) * | 2009-09-25 | 2012-08-29 | 武汉市紫物源科技有限责任公司 | Polysaccharide back source nutrient |
| CN103638053A (en) * | 2013-11-25 | 2014-03-19 | 大理学院 | Preparation method and medical purpose of effective position of Odontoponera transversa Smith |
| CN104546925A (en) * | 2015-02-06 | 2015-04-29 | 江西中天医药生物有限公司 | Termite capsule and preparation method thereof |
| CN104667044A (en) * | 2015-02-15 | 2015-06-03 | 广西双蚁药业有限公司 | Traditional Chinese medicine preparation for treating arthralgia and preparation method of traditional Chinese medicine preparation |
| CN105410937A (en) * | 2015-06-23 | 2016-03-23 | 新疆环拓生物科技有限公司 | Production process of beatifying calcium dispersible tablet |
| CN105495603A (en) * | 2016-01-04 | 2016-04-20 | 环翠楼红参生物科技股份有限公司 | Preparation method for radix ginseng rubra-fructus crataegi cell-wall breaking superfine powder |
| CN105497519A (en) * | 2016-01-04 | 2016-04-20 | 环翠楼红参生物科技股份有限公司 | Preparation method for radix ginseng rubra-colla corii asini cell-wall breaking superfine powder |
| CN105595335A (en) * | 2016-01-04 | 2016-05-25 | 环翠楼红参生物科技股份有限公司 | Preparation method of radix ginseng rubra and maca cell-wall breaking ultra-fine powder |
| CN112245456A (en) * | 2020-10-19 | 2021-01-22 | 广西壮族自治区中医药研究院 | Application of polyrhachis vicina Roger extract in preparation of anti-cerebral ischemia drugs |
-
2004
- 2004-10-20 CN CNB2004100096890A patent/CN1275545C/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101669646B (en) * | 2009-09-25 | 2012-08-29 | 武汉市紫物源科技有限责任公司 | Polysaccharide back source nutrient |
| CN103638053A (en) * | 2013-11-25 | 2014-03-19 | 大理学院 | Preparation method and medical purpose of effective position of Odontoponera transversa Smith |
| CN104546925A (en) * | 2015-02-06 | 2015-04-29 | 江西中天医药生物有限公司 | Termite capsule and preparation method thereof |
| CN104546925B (en) * | 2015-02-06 | 2018-05-25 | 江西中天医药生物有限公司 | Termite capsule and preparation method thereof |
| CN104667044A (en) * | 2015-02-15 | 2015-06-03 | 广西双蚁药业有限公司 | Traditional Chinese medicine preparation for treating arthralgia and preparation method of traditional Chinese medicine preparation |
| CN105410937A (en) * | 2015-06-23 | 2016-03-23 | 新疆环拓生物科技有限公司 | Production process of beatifying calcium dispersible tablet |
| CN105495603A (en) * | 2016-01-04 | 2016-04-20 | 环翠楼红参生物科技股份有限公司 | Preparation method for radix ginseng rubra-fructus crataegi cell-wall breaking superfine powder |
| CN105497519A (en) * | 2016-01-04 | 2016-04-20 | 环翠楼红参生物科技股份有限公司 | Preparation method for radix ginseng rubra-colla corii asini cell-wall breaking superfine powder |
| CN105595335A (en) * | 2016-01-04 | 2016-05-25 | 环翠楼红参生物科技股份有限公司 | Preparation method of radix ginseng rubra and maca cell-wall breaking ultra-fine powder |
| CN112245456A (en) * | 2020-10-19 | 2021-01-22 | 广西壮族自治区中医药研究院 | Application of polyrhachis vicina Roger extract in preparation of anti-cerebral ischemia drugs |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1275545C (en) | 2006-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104256584B (en) | A kind of Moringa ferment and preparation method thereof | |
| CN1931993A (en) | Health yellow wine of ginseng and lily and its prepn process | |
| CN1275545C (en) | Eatable ants and its preparation method | |
| CN101028070A (en) | Mangosteen extract, its production and use | |
| CN1308431C (en) | Buck-wheat flavone vinega soft capsule and preparing method | |
| CN1535605A (en) | Drink and food | |
| CN1290441C (en) | Rye-red yeast vinegar soft capsule and its preparing method | |
| CN1461606A (en) | Health-care fruit and vegetable food with function of looseing bowel to relieve constipation and its prodn. method | |
| CN1203168C (en) | Process for preparing dietetic health vinegar, and dietetic heath vinegar produced thereby | |
| CN1207902A (en) | Antilipemic monascus and its preparation | |
| CN104542862B (en) | Agropyron dietary-fiber biscuit and preparation method thereof | |
| CN1098628A (en) | Coptotermes formosanus Shtrari. and bacterium plot series preparations thereof | |
| CN1186091C (en) | Chinese medicine injection and its production process | |
| CN1061537C (en) | Monascus preparation for hyperlipemia and relevant cardiac and cerebral diseases | |
| CN106071589A (en) | With Herba Dendrobii juice for a kind of Ganoderma biological drink of carrier preparation | |
| CN1884503A (en) | Bamboo leaf SOD preparation and functionalized food containing bamboo leaf SOD | |
| CN1281161C (en) | Anti-fatigue health-care food and production thereof | |
| CN107841411A (en) | A kind of processing method of health-care rice wine | |
| CN1466990A (en) | Health food for protecting liver and adjusting blood fat and method for preparing the same | |
| CN1596935A (en) | Medicine for treating baby and child diarrhea and its preparation method | |
| CN1313102C (en) | Health caring capsule of soft-shelled turtle and its preparation method | |
| CN1166391C (en) | Anti-drunk-enness and sobering up composition and its preparing method | |
| CN1155421A (en) | Preparation of rice fermented with red yeast for curing hyperlipemia and cardio-cerebral diseases concerned | |
| CN1314110A (en) | Health drink of purslane and hairyvein agrimonia and its preparing method | |
| CN107810918A (en) | A kind of cultural method of No. two chickens in Plain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Beijing long and open source nutrition nutrition Technology Co., Ltd. Assignor: Beijing Dongfang Xingqi Food Product Industry Techn Co., Ltd. Contract fulfillment period: 2008.3.4 to 2014.3.3 contract change Contract record no.: 2009110000120 Denomination of invention: Eatable ants and its preparation method Granted publication date: 20060920 License type: Exclusive license Record date: 2009.5.25 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.3.4 TO 2014.3.3; CHANGE OF CONTRACT Name of requester: BEIJING JIUHE OPEN-SOURCE NUTRITION SCIENCE CO., L Effective date: 20090525 |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060920 Termination date: 20091120 |